Fact CheckerSign in

NCT05638841Recruiting

Prospective Cohort Study of the Risk of Recurrent Atrial Fibrillation After Radiofrequency Ablation

Source: ClinicalTrials.gov · Last updated 21 Feb 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

In this study, the continuous inclusion of atrial fibrillation patients treated by catheter ablation in the Department of Cardiology, Peking University Third Hospital, through the collection of clinical data and outpatient follow-up, to explore the risk factors of atrial fibrillation recurrence after catheter ablation and the influencing factors of major clinical events in atrial fibrillation patients, and further guide the management mode of atrial fibrillation patients.

Status (registry)
Recruiting
Study type
Observational
Enrollment
300 (estimated)
First submitted
28 Nov 2022
Start date
1 Jan 2023
Primary completion date
31 Dec 2024
Lead sponsor
Peking University Third Hospital
NCT number
NCT05638841

What you commit to

  • Study type: Observational
  • Planned participants: 300
  • From 1 Jan 2023 to the primary completion date, 31 Dec 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • 1\) Hematological diseases, autoimmune diseases and malignant tumors
  • 5\) Disorders of consciousness or Alzheimer's disease

Other

  • 2\) Immobility caused by hemiplegia or severe trauma
  • 3\) The expected survival time is less than 2 years
  • 4\) Poor compliance and high risk of expected loss of follow-up

Who the study is looking for

  • 1\) Age \> 18
  • 2\) ECG or holter electrocardiogram confirmed atrial fibrillation

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Peking University Third Hospital
Coordinator of this site? Confirm its status
BeijingChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.